Muscarinic autoreceptors on horse airway cholinergic nerves were studi
ed by examining the effects of muscarinic receptor antagonists on elec
trical field stimulation (EFS)-induced acetylcholine (ACh) release in
trachealis preparations. All the antagonists including atropine (non-s
elective), pirenzepine (M(1)-selective), AF-DX 116 (M(2)-selective), a
nd hexahydrosiladifenidol (M(3)-selective) augmented ACh release conce
ntration-dependently. The augmentation was not due to displacement of
ACh molecules from tissue receptors into the bath liquid because incub
ation with atropine after EFS had no influence on the measured amount
of ACh. Hexahydrosiladifenidol was more potent in inhibiting ACh-induc
ed muscle contraction, which is known to be mediated by M(3) receptors
, than in augmenting ACh release. The maximal ACh release rate in resp
onse to the selective antagonists was much less than that following at
ropine. Furthermore, the concentrations of the selective antagonists r
equired to augment ACh release far exceeded their K(d)s for M(1), M(2)
, or M(3) receptors. These observations suggest that the muscarinic au
toreceptors on horse airway cholinergic nerves may belong to a novel s
ubtype.